Ra Pharmaceuticals, Inc. 4 SEC Filings

Filed On	Filing
03 Apr 2020	Form 4: New Enterprise Associates 13 Lp, 10% owner and 5 others Returned 6,135,234 shares to the issuer
03 Apr 2020	Form 4: Mathers Edward T, Director Disposed of 45,000 Stock Option (Right to Buy) (Disposition to Issuer)
03 Apr 2020	Form 4: Treco Douglas A, Director Returned 234,707 shares to the issuer ($11.3M) · Disposed of 1,206,116 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 20,833 Restricted Stock Units (Disposition to Issuer)
03 Apr 2020	Form 4: Lubner David Charles, Executive VP and CFO Returned 15,622 shares to the issuer ($750K) · Disposed of 544,426 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 10,416 Restricted Stock Units (Disposition to Issuer)
03 Apr 2020	Form 4: Ricardo Alonso, See Remarks Returned 2,973 shares to the issuer ($143K) · Disposed of 271,820 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 4,375 Restricted Stock Units (Disposition to Issuer)
03 Apr 2020	Form 4: Read Simon, Chief Scientific Officer Returned 12,595 shares to the issuer ($605K) · Disposed of 327,356 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 9,166 Restricted Stock Units (Disposition to Issuer)
03 Apr 2020	Form 4: Farzaneh-Far Ramin, Chief Medical Officer Returned 14,492 shares to the issuer ($696K) · Disposed of 370,264 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 10,416 Restricted Stock Units (Disposition to Issuer)
03 Apr 2020	Form 4: Cumbo Alexander, Director Disposed of 40,000 Stock Option (Right to Buy) (Disposition to Issuer)
03 Apr 2020	Form 4: Pearson Timothy R, Director Disposed of 67,857 Stock Option (Right to Buy) (Disposition to Issuer)
03 Apr 2020	Form 4: King John C, Chief Commercial Officer Returned 10,823 shares to the issuer ($520K) · Disposed of 297,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 30,658 Restricted Stock Units (Disposition to Issuer)
03 Apr 2020	Form 4: Shah Rajeev M., Director Returned 4,858,260 shares to the issuer ($233M) · Disposed of 45,000 Stock Option (Right to Buy) (Disposition to Issuer)
03 Apr 2020	Form 4: Heft Robert, Director Disposed of 67,857 Stock Option (Right to Buy) (Disposition to Issuer)
03 Apr 2020	Form 4: Ra Capital MANAGEMENT, L.p., Director and 2 others Returned 4,858,260 shares to the issuer ($233M)
03 Apr 2020	Form 4: Brennan Aoife, Director Disposed of 40,000 Stock Option (Right to Buy) (Disposition to Issuer)
18 Mar 2020	Form 4: Ricardo Alonso, See Remarks Sold 2,288 shares ($101K)
18 Mar 2020	Form 4: Farzaneh-Far Ramin, Chief Medical Officer Received 10,595 shares by exercise or conversion ($59.3K) · Sold 10,595 shares ($479K)
20 Feb 2020	Form 4: Farzaneh-Far Ramin, Chief Medical Officer Received 10,595 shares by exercise or conversion ($59.3K) · Sold 10,595 shares ($494K)
21 Jan 2020	Form 4: Ricardo Alonso, See Remarks Sold 2,285 shares ($107K)
16 Jan 2020	Form 4: Farzaneh-Far Ramin, Chief Medical Officer Received 10,595 shares by exercise or conversion ($59.3K) · Sold 10,595 shares ($497K)
18 Dec 2019	Form 4: Ricardo Alonso, See Remarks Sold 2,285 shares ($108K)

Comments